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invasive and with risk of complications to the patient. Magnetic resonance imaging (MRI) has been
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gland disease they do not assess duct abnormalities. The introduction of magnetic resonance sialog-
raphy (MRS) protocol was the ﬁrst step towards non-ionizing non-invasive technique enables a
more accurate assessment of the duct system. Moreover, it is postulated that the combined use
of MRI and MRS is useful for the assessment of damaged salivary glands in SS..M. El-Wakd).
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148 N.S. Ahmed et al.Aim of work: This preliminary study aimed to assess the role and efﬁcacy of MRS and MRI in
imaging the parotid gland in SS patients’ and to compare their results with that of CS in the
diagnosis and staging of SS.
Patients and methods: The parotid gland was examined by MRS, MRI and CS in 15 SS patients.
Scoring system for overall branching pattern, ductal system staging, sialectasis for both CS and
MRS was used. MRI scoring system for glandular parenchymal pattern, size and contour and
lymph node was used.
Results: This revealed non-signiﬁcant difference between CS and MRS ﬁndings in the diagnosis
and staging of SS. Furthermore, no statistically signiﬁcant correlation was found between the clin-
ical and SS stage in both CS and MRS. On the other hand, a statistically signiﬁcant positive cor-
relation was found between the clinical ﬁndings and the MRI parenchymal stages. Moreover,
MRS showed higher sensitivity and diagnostic accuracy values than CS. Combining the MRS
and MRI abnormalities, 100% sensitivity diagnostic accuracy values were achieved in the diagnosis
and staging of SS. The inter-observer agreement was higher in MRS than in CS and was perfect in
MRI.
Conclusion: In this preliminary study, MRS showed a higher sensitivity and accuracy in diagnos-
ing and staging SS and may safely and securely replace CS. MRI and MRS give information on
different aspects of glandular and duct pathology; therefore, both should be performed when exam-
ining the parotid glands in SS patients.
 2011 Egyptian Society for Joint Diseases and Arthritis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Sjo¨gren’s syndrome (SS) is a chronic systemic autoimmune
disease characterized by lymphocytic inﬁltration of exocrine
glands particularly the salivary and lacrimal glands interfer-
ing with the normal gland function resulting in dry mouth
and eyes [1,2]. The diagnosis is based on the combined eval-
uation of multiple clinical, serological, functional, histopa-
thological and morphological parameters [2–4]. Minor
salivary gland biopsy and conventional sialography (CS) have
been considered the cornerstones of the diagnosis of SS [5,6].
However, they are both invasive examinations that may cause
inconvenience and a risk of complications, such as dye reten-
tion, inability to duct cannulation and intra- or post-proce-
dure pain [7,8]. Ultrasonography and magnetic resonance
imaging (MRI) have been widely replacing conventional inva-
sive examinations. They provide insufﬁcient data for accu-
rately diagnosing and staging SS, because while they
address the detection and diagnosis of parenchymal diseases
of salivary glands they do not assess salivary gland duct
abnormalities [8–12]. The introduction of magnetic resonance
sialography (MRS) protocol was the ﬁrst step towards non-
ionizing non-invasive technique enables a more accurate
assessment of the duct system [13]. Moreover, it is postulated
that the combined use of high resolution MRI, by T1
weighted or fat-suppressed T2-weighted imaging, and MRS
is useful for the assessment of damaged salivary glands in
SS. However, careful validation of MRI ﬁndings is required
before the importance of these ﬁndings is established with re-
spect to disease activity. If properly validated, high resolution
MRI of the salivary glands may become a powerful noninva-
sive test for examining and staging damages to the glands in
SS [14], and for differentiation from other diseases that mimic
SS [8,15]. This preliminary study aimed to assess the role and
efﬁcacy of MRS and MRI in imaging the parotid gland in SS
patients’ and to compare their results with that of CS in the
diagnosis and staging of SS.2. Patients and methods
2.1. Patients
Fifteen female SS patients were selected from the Rheumatology
and Rehabilitation Department, Faculty of Medicine, Cairo
University according to the revised version of the European cri-
teria proposed by the American-European Consensus Group
[3]. They were subjected to thorough history taking and clinical
examination both systemic and local to the parotid gland area.
2.1.1. MRI examination
For each patient, either right or left parotid gland was
examined by using a 1.5-T superconductive magnet (Philips;
Gyroscan Intera; Netherlands). A surface coil was used. Axial
T1-weighted images (T1WI) and axial STIR (short time inver-
sion-recovery) images were performed. T1WI: was performed
with the following parameters: Repetition time (TR): 525, echo
time (TE): 13, number of signal averages/excitations (NSA/
NEX): 8, ﬁeld of view (FOV): 7 cm, image matrix: 256 · 256,
slice thickness: 2 mm, inter-slice gap: no gap, imaging time:
3 min and 46 s, STIR images: were performed with the follow-
ing parameters: TR: 2650, TE: 90, NSA/NEX: 8, FOV: 7 cm,
image matrix: 256 · 256, slice thickness: 2 mm, inter-slice gap:
no gap and imaging time: 5 min.
2.1.2. MRS
Sagittal MRS images were performed using single section sin-
gle-shot turbo spin-echo (SSTSE) sequence with the following
parameters: TR: 8000, TE: 900, NSA/NEX: 8, FOV: 7 cm,
image matrix: 256 · 256, slice thickness: 3 cm and imaging
time: 48 s. A rectangular image area for MRS was deter-
mined on the axial STIR images and its long axis was placed
parallel to the course of the main duct. The slice thickness
was thick so that the whole gland area was included in the
image area.
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All patients underwent CS after MRI and MRS examinations
by using the angiography system (Diagnost 94; Philips;
Holland).
2.1.4. Scoring system for CS ﬁndings
The normal parotid sialogram shows continuous branching of
the ductal system tapering off towards the periphery of the
glands, smooth contours of the main duct and ductal branches
and no sialectasias. A rariﬁed ductal system, irregular or de-
stroyed ductal contours, occlusions and sialectasiaswere consid-
ered pathologic ﬁndings [16]. Overall branching pattern:
Normal: 0. Sparse: 1. The width and contour of Duct system:
(main duct, primary and secondary ductal branches): Normal:
0, narrowwith or without irregularity: 1, dilated with or without
irregularity: 2, and destroyed: 3. The sialectasis: based on the
widely accepted criteria proposed by Rubin and Holt [17].
According to the size of contrast material collections inside the
gland: Stage-0:No sialectasis. Stage-I: Punctate;<1 mm indiam-
eter. Stage-II:Globular; 1–2 mm indiameter. Stage-III: Cavitary;
>2 mm in diameter. Stage-IV: Destructive; severe irregular dila-
tation of the main duct and destruction of the parenchyma with
pooling of contrast medium giving a bizarre pattern. Diagnosis
of SS was made when the ﬁndings of CS showed stage 1 disease
or greater. According to the number of sialectasia: Absent: 0.
Few: 1. Many: 2. Each of accessory duct/gland, ﬁlling defect
and stricture were given 0 if absent and 1 if present.
2.1.5. Scoring system for MRS ﬁndings
The same scoring system of CS ﬁndings was applied to theMRS
ﬁndings; where the MRS staging was determined according to
the size of the high signal intensity areas inside the gland.
2.1.6. Scoring system for MRI ﬁndings
2.1.6.1. Glandular parenchymal pattern. It was relied on T1WI
and STIR images. This was a ‘‘Modiﬁcation’’ to the staging sys-
tem of Takagi et al, 2005 [2]. Stage-0: Normal, the parotid gland
is of homogenous intermediate signal intensity denoting intact
gland parenchyma. Stage-I: Mild distribution of heterogeneous
parenchymal pattern (<25%of the total gland area)within nor-
mal parenchyma. Stage-II: Moderate distribution of heteroge-
neous parenchymal pattern (25–50% of the total gland area)
within normal parenchyma. Stage-III: Advanced distribution
of heterogeneous parenchymal pattern (50–75 % of the total
gland area) within normal parenchyma. Stage-IV: Severe, there
is a diffused distribution of heterogeneous parenchymal pattern
(>75% of the gland area). Gland size: Normal: 0. Enlarged: 1.
Gland contour: Smooth: 0. Irregular: 1. Accessory gland: Ab-
sent: 0. Present: 1. Lymph nodes: Absent: 0. Present: 1.
2.1.7. Image analysis
MRI, MRS and CS were evaluated independently by three
radiologists. The ﬁndings of CS were used as the standard of ref-
erence. Four-point scale for the evaluation of the image quality
regarding clarity, visibility and resolution to determine the inter-
observer agreement in each imaging modality: 0 = Poor images.
1 = Fair images. 2 = Good images. 3 = Very good images.
The current study design was discussed and approved by
the Selected-Review-Board, Faculty of Oral and Dental Med-
icine, Cairo University, on May 2007. A written informed con-
sent was obtained from all the patients sharing in the study.Statistics: Qualitative data were presented as frequencies
and percentages. Chi square test was used for comparisons
between the variables. Yates’ correction was used to prevent
overestimation of statistical signiﬁcance for small data. This
formula was chieﬂy used when at least one cell of the table
had count smaller than ﬁve. Quantitative data were pre-
sented as means and SD values. Spearman’s correlation coef-
ﬁcient was used to determine signiﬁcant correlations between
different variables. The signiﬁcance level was set at P 6 0.05.
Statistical analysis was performed with SPSS (Statistical
Package for Scientiﬁc Studies) 16.0 for Windows. Sensitiv-
ity, Speciﬁcity and Diagnostic accuracy were calculated as
follows:Sensitivity ð%Þ ¼ True positive
True positiveþ false negative 100
Diagnostic accuracy ð%Þ ¼ True positiveþ True negative
Total number
 100Kappa statistic was used to measure the agreement between
the evaluations of the different raters (Inter-observer agree-
ment). A value of 1 indicates perfect agreement; it is zero when
there is no agreement. Kappa values can be interpreted as fol-
lows: poor (<0.2), fair (0.21–0.4), moderate (0.41–0.6), good
(0.61–0.8) and very good (0.81–1.00).3. Results
The patient’s age varied from 30 to 57 years with mean of
42.5 ± 10 years with disease duration varied from 2 to
15 years with a mean of 6.1 ± 3.8 years. All of them have
keratoconjunctivitis sicca and 14 have Extra-glandular mani-
festations (93.3%). Recurrent parotid gland swelling was
noted in 9 (60%) patients.3.1. Comparison between CS and MRS ﬁndings
The ﬁndings between CS and MRS is demonstrated in Table 1
and Figs. 1–4.3.2. MRI ﬁndings
Glandular parenchymal pattern: stage-0 was found in one
(6.7%) patient, stage-I in 7 (46.7%) patients; stage-II, III
and IV in 3 (20%) patients for each. Gland size: 7 patients
(46.7%) had enlarged parotid gland. Gland contour: 7 patients
(46.7%) had irregular parotid gland. Other ﬁndings: accessory
gland was detected in 12 (80%) patients and lymph node
enlargement in 11 (73.3%) patients. Different patterns were
shown in ﬁg. 5.3.3. Laboratory ﬁndings
Positive anti Ro/La antibodies were found in 11 (73.3%)
patients.
Table 1 Comparison between CS and MRS ﬁndings.
Findings Group P-value
CS (n= 14) MRS (n= 15)
Frequency % Frequency %
Overall branching pattern
Normal 5 35.7 4 26.7 0.6
Sparse 9 64.3 11 73.3
The duct system
Main duct Normal 5 35.7 6 40 0.984
Narrow 2 14.3 2 13.3
Dilated 7 50 7 46.7
1ry branches Normal 6 42.9 7 46.7 0.979
Narrow 1 7.1 1 6.7
Dilated 7 50 7 46.7
2ry branches Normal 7 50 3 20 0.192
Narrow 2 14.3 5 33.3
Dilated 2 14.3 2 13.3
Destroyed 3 21.4 5 33.3
Sialectasis
Size Stage-0 No sialectasis 3 21.4 2 13.3 0.7
Stage-I Punctate 7 50 8 53.3
Stage-II Globular 3 21.4 3 20
Stage-III Cavitary 1 7.1 2 13.3
Stage-IV Destructive 0 0
Number Absent 3 21.4 2 13.3 0.66
Few 6 42.9 10 66.7
Many 5 35.7 3 20
Other ﬁndings
Accessory gland/duct 7 50 12 80 0.09
Filling defect 2 14.3 0 0 0.13
Stricture 6 42 6 40 0.59
Figure 1 Overall branching pattern of the parotid gland by CS;
normal (left) and sparse (right).
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coefﬁcient test
Ductal stage and SS stage (sialecatic stage) in both CS and
MRS showed no statistically signiﬁcant correlation (P>
0.05). MRI parenchymal stage and MRS SS stage (sialecatic
stage) showed no statistically signiﬁcant correlation (P>
0.05). MRI parenchymal stage and MRS ductal stage showed
a statistically signiﬁcant positive correlation between MRI
parenchymal stage and 1ry & 2ry branches (P= 0.04 and
0.03 respectively). SS stage (sialecatic stages) and age, diseaseduration, clinical and laboratory ﬁndings in both CS and
MRS showed no statistically signiﬁcant correlation. Main
ductal stage in both CS and MRS and age, disease duration,
clinical, laboratory ﬁndings in both CS and MRS showed no
statistically signiﬁcant correlation. There were a statistically
signiﬁcant positive correlation between age (P< 0.001), dis-
ease duration (P= 0.004), recurrent parotid swelling (P=
0.027) and MRI parenchymal pattern. There was a statistically
signiﬁcant positive correlation between anti Ro/La antibodies
and parenchymal pattern (P= 0.02). There was no statisti-
cally signiﬁcant correlation between parenchymal pattern
ﬁndings and extra-glandular manifestations.
3.5. Diagnostic performance of the imaging modalities
MRS showed higher sensitivity and diagnostic accuracy values
(86.7% for each) than CS (78.6% for each) when the presence
of sialectasis was taken as the reference for the diagnosis of SS.
Moreover, MRS showed slightly higher sensitivity and diag-
nostic accuracy (93.3% for each) than CS (92.9% for each)
when any abnormality of the ductal system and sialectasis were
considered positive for SS. As regard the MRI ﬁndings, the
parenchymal stage has high sensitivity and diagnostic accuracy
values (93.3% for each), however diagnosis based on gland size
or contour yield a very low sensitivity and accuracy values
(46.7% for each). Combining MRS and MRI revealed 100%
sensitivity and 100% diagnostic accuracy in the diagnosis of
SS.
Figure 2 Duct system. CS showed (A) stage-0, (B) stage-I and
(C) stage-II. MRS showed (D) stage-0, (E) stage-I and (F) stage-II.
Figure 3 Sialectasis. CS showed: (A) SS stage-I, (B) SS stage-II, (C)
stage-III.
Figure 4 CS (left) and MRS (right). Accessory parotid gland
(black star), ﬁlling defect (black arrow head) and main duct
stricture (white star).
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As regard CS, there was a statistically signiﬁcant agreement
between all observers (P< 0.001) as regards the main duct;
the agreement ranged from moderate (0.573) to good (0.632).
As regards the secondary branches, signiﬁcant agreement
(P< 0.001) was only found between Observer 2 and observer
3; the agreement was good (0.712). There was non-statistically
signiﬁcant agreement as regards the overall branching pattern,
1ry branches and sialectasis.
As regard MRS, there was a statistically signiﬁcant perfect
(1.00) agreement between all observers (P< 0.001) as regards
the main duct. Moreover, there was a statistically signiﬁcant
agreement between all observers (P< 0.005) as regards the
sialectasis; the agreement ranged from moderate (0.559) to
very good (0.865). As regards the overall branching pattern,
signiﬁcant good (0.745) agreement was only found between ob-
server 2 and 3. As regards the primary branches, signiﬁcant
moderate (0.471) agreement was found between Observer 1
and 3. The same agreement happened between Observer 2
and 3. While; for secondary branches; signiﬁcant moderate
(0.559) agreement was only found between Observer 2 and 3.SS stage-III. MRS showed: (D) SS stage-I, (E) SS stage-II, (F) SS
Figure 5 Parotid gland parenchymal pattern (above); T1WI showed (left to right) normal homogenous gland, mild, moderate, advanced,
and severe heterogenous gland pattern. Parotid gland contour (below); STIR image showed regular (left) and irregular gland contour
(middle). Lymph node enlargement (right).
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ment between all observers (P< 0.001) as regards parenchy-
mal pattern and gland contour where the agreement was
perfect (1.00).
4. Discussion
This preliminary study aimed to assess the role and efﬁcacy of
MRS and MRI in imaging the parotid gland in SS patients’
and to compare their results with that of CS in the diagnosis
and staging of SS.
According to our results, both modalities (MRI/MRS and
CS) showed similar stages of the main and primary ductal
branches. The main duct was normal in 35.7% in CS versus
40% in MRS (where CS was technically failed in one patient
whose main duct was normal in MRS); narrow in 14.3% in
CS versus 13.3% in MRS and dilated in 46.7% in CS versus
50% in MRS. No destroyed main ducts. Regarding the pri-
mary ductal branches, both modalities showed similar ductal
stages. However, Stiller et al. [16] found that 56.5% of sialo-
grams revealed normal main ducts, 34.8% revealed narrow
main duct and 8.7% revealed dilated ducts. No destroyed main
ducts were observed. Additionally, MRS ﬁndings of Niemela¨
et al. [18] revealed that 3.8% of patients had normal ducts;
65.4% had narrow ducts and 30.8% had dilated ducts. In
the present study, the secondary ductal branches were narrow
or destroyed in 35.7% in CS versus 66.6% in MRS; yet, these
differences were statistically non-signiﬁcant. Taking CS as the
gold standard reference, the higher percentage of narrowing in
MRS may be due to the non-use of sialogogue in our study
resulting in improper visualization of the minor ductal
branches. Ductal structures were delineated more clearly after
stimulation with a sialogogue [19,20]. Furthermore, CS offers
higher spatial resolution than MRS in the assessment of sec-ondary and tertiary ductal branches; however this was not very
important as the diagnosis of the disease is often not affected
[21,22].
Diagnosis of SS depends upon the sialectasis and the stage
is determined according to its size, which is important in both
the initial diagnosis and the follow-up as it has an effect on the
treatment plan and on the prognosis [23]. In the current study,
the SS stage-0 was found in 21.4% in CS versus 13.3% in
MRS, however, stage-1 was observed in 50% in CS versus
53% in MRS; this was due to one patient was judged as stage
0 in CS and stage 1 in MRS. This ﬁnding may be attributed to
the severe pain experienced by the patient during injection
which was stopped immediately afterwards resulting in incom-
plete ﬁlling of the ductal system, thus sialectasis were not
apparent in CS. On the contrary, Takagi et al. [8] in their study
found that some patients with grade 0 in MRS showed grade 1
changes in CS. Stage-2 was observed in 21.4% in CS and 20%
in MRS; stage-3 was observed in 7.1% in CS versus 13.3% in
MRS. These results came in agreement with the results of later
study who found that MRS ﬁndings were well correlated with
CS in stages 2 and 3 of the disease8. In our study, no stage-4
was found among our patients. Despite the previous ﬁgures,
our results showed no statistically signiﬁcant differences
between the CS and MRS regarding the disease staging. More-
over, in 86.6% of patients the stage of SS determined with
MRS was identical to that determined with CS. Almost near
to our results; Ohbayashi et al. [24] found that CS stages
and MRS stages were well correlated in 89% of their patients.
Also, Yu CQ et al. [15], in their study found that 83.3% of pa-
tients have the same manifestations by degree classiﬁcation.
However, Tonami et al. [23] in their study had found similar
stages in 50% of patients.
With regards to the number of sialectasis, our study re-
vealed many sialectasis in 35.7% patients in CS versus 20%
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ent aspects of the disease where in CS sialectasis represent
dilated intraglandular ducts besides areas of pooled contrast
material due to fragmentation of the duct walls. However,
MRS is a hydrography technique that represents the water rich
structures only. The non-signiﬁcant differences established be-
tween CS and MRS ﬁndings and staging of SS, more to the
point the complications of CS, all these suggested that MRS
can be safely and securely replace the invasive CS in the diag-
nosis and staging of SS.
According to MRI results, T1WI revealed high signal inten-
sity areas throughout the gland which were changed to low sig-
nal intensity on STIR images. Four stages were suggested.
These changes yielded a heterogeneous parenchymal pattern
in 93.3% patients; where stage-I was found in 46.7% patients,
stage-II in 20% patients, stage-III in 6.1% patient and stage-
IV in 20% patients. In accordance with our results, Izumi
et al. [25] noticed that the parotid glands in SS showed heter-
ogeneity of signal intensity on MRI and believed that this may
indicate the presence of hemorrhage, proteinaceous content, or
fat tissue. In 1997 [26], they performed another study and
found that the high-intensity signals in T1WI which were sup-
pressed in STIR images proving that these areas deﬁnitely
areas of fat deposition. Additional study found that glands af-
fected with SS were heterogeneous and consisted of low and
high signal intensity areas (representing fat and intact lobule
areas) [8]. As well, other MRI studies found that adipose
degeneration or nodular parenchyma is considered the most
accurate ﬁnding of SS patients’ salivary glands [10,18]. There-
fore, in our study we performed MRI using T1WI and STIR
sequences to monitor the fat deposition in SS which might
be useful in diagnosing and staging of the disease and assessing
its progress in patients whose clinical and serologic ﬁndings are
suggestive of the disease.
Regarding the gland size, the present study revealed parotid
enlargement in 46.7% patients. Other studies reported that
parotid enlargement may be a feature of SS in approximately
50% of patients [27,28]. Glandular contour was irregular in
46.7% patients. This ﬁnding was also reported in an ultrasono-
graphic texture analysis of the parotid gland in SS [29]. Lymph
node enlargement was observed in 73.3% patients. Parotid
lymphoma was reported to occur in SS [30]; however, in this
study no evidence of parotid tumors was observed.
In the present study, on correlating the ductal stages and SS
stages, no statistically signiﬁcant correlation was found in both
CS and MRS. Also, on correlating the SS stages in MRS and
MRI parenchymal stage, no statistically signiﬁcant correlation
was found. On the other hand, a statistically signiﬁcant posi-
tive correlation was found between the MRI parenchymal
stage and the ductal stage of the primary and secondary
branches in MRS, this means that increase in destruction of
primary and secondary branches is associated with an increase
in severity of parenchymal damage. These ﬁndings in line with
those who stated that, with disease progression, complete
destruction of the minor duct radicals occur. Additionally,
once fat deposition develops the parenchyma will be lost for-
ever [18,26,31].
On correlating the SS stage in both the CS and MRS with
the clinical and laboratory ﬁndings, no statistically signiﬁcant
correlation was found. On the other hand, a statistically signif-
icant positive correlation was found between MRI parenchy-
mal pattern and age, disease duration, anti Ro/La antibodiesand recurrent parotid swelling. This means that, an increase
in age, disease duration, recurrent parotid swelling and anti
Ro/La were associated with an increase in heterogeneity of
parenchymal pattern. As in our study, Niemela¨ et al. [18] sta-
ted that the presence of anti-Ro/La antibodies was associated
with the parenchymal ﬁndings on parotid MRI.
According to our results, the positive correlations found be-
tween MRI stages and the clinical ﬁndings suggest that the
MRI parenchymal staging used in our study may be used as
a diagnostic method to reﬂect the severity of the disease. More-
over, the absence of correlation between the CS and MRS dis-
ease staging and the clinical ﬁndings emphasizes the
importance of sialographic examination in the diagnosis and
staging of the disease.
When sialectasis was taken as a reference for the diagnosis
of SS, MRS showed higher sensitivity and diagnostic accuracy
than CS (86.7% versus 78.6% respectively) which in close
proximity to Markusse et al. [32] who found that the diagnos-
tic sensitivity of CS was 79%. On the other hand, other study
showed MRS sensitivity of 73% and diagnostic accuracy of
83% [7]. Yu et al. [15] showed higher sensitivity and diagnostic
accuracy values (92% and 87.5% respectively) of MRS than
ours. In our study, one patient showed severe main duct dila-
tation and irregularity without evidence of sialectasis in both
modalities. Accordingly, this patient was falsely judged as neg-
ative for SS. Therefore, we recommend considering the duct
abnormalities together with the presence of sialectasis in the
diagnosis of SS. This increased the sensitivity and diagnostic
accuracy values of both MRS and CS (93.3% and 92.7%
respectively). The MRI parenchymal stage in our study dem-
onstrated 93.3% sensitivity and diagnostic accuracy values.
It is worth mentioning that one of our patients showed normal
sialographic ﬁndings, however, stage-I heterogeneous paren-
chymal pattern was observed. Therefore, we attempted to com-
bine MRS with MRI parenchymal pattern abnormalities for
further approach to a more accurate diagnosis. Interestingly,
this combination showed 100% sensitivity and 100% diagnos-
tic accuracy in the diagnosis of and staging of SS. Likewise, in
a previous study a combination of T1WI and fat suppressed
T2WI MRI and MRS yielded a high sensitivity value (96%)
[8].
Results of Kappa statistic for the inter-observer agreement
in interpreting the CS revealed moderate to good agreement
regarding the main duct ﬁndings and the secondary ductal
branches. However, poor to fair agreement was found regard-
ing the remaining other ﬁndings. However, as regard MRS,
there was a perfect agreement between all observers for the
main duct; moderate to very good agreement for the sialecta-
sis; good agreement was found between two observers for
the overall branching pattern and moderate agreement for
the ductal system branches. Also, there was a perfect agree-
ment between all observers as regards parenchymal pattern
and gland contour in MRI. This denotes that the diagnostic
reliability of MRS is higher than CS, thus MRS can securely
replace CS in the diagnosis of SS.
In conclusion, from this preliminary study, MRI/MRS is
valuable in the evaluation of the salivary glands in SS since
the clinical proﬁle of the patients is not correlated with the
severity of the disease. Also, MRS is proved to be a sensitive
and highly accurate imaging for the diagnosis and staging of
SS and may securely replace CS in the evaluation of SS.
MRI and MRS give information on different aspects of
154 N.S. Ahmed et al.glandular pathology; therefore, both should be performed
when examining the parotid glands in SS.
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